Cargando…

Editorial: Drug resistance in lung cancer chemotherapy and personalized chemotherapy

Detalles Bibliográficos
Autor principal:	Li, Lianbo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cell and Developmental Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9424987/ https://www.ncbi.nlm.nih.gov/pubmed/36051437 http://dx.doi.org/10.3389/fcell.2022.971477

Ejemplares similares

Editorial: Adopting drug repurposing to overcome drug resistance in cancer
por: Shankar, Eswar, et al.
Publicado: (2023)

Editorial: Non-genetic adaptive drug resistance in cancer
por: Cerezo, Michaël, et al.
Publicado: (2022)

Integrated proteomics and phosphoproteomics revealed druggable kinases in neoadjuvant chemotherapy resistant tongue cancer
por: George, Irene A., et al.
Publicado: (2022)

GADD45B Is a Potential Diagnostic and Therapeutic Target Gene in Chemotherapy-Resistant Prostate Cancer
por: Wang, Qiong, et al.
Publicado: (2021)

The Influence of Oncogenic RAS on Chemotherapy and Radiotherapy Resistance Through DNA Repair Pathways
por: Cáceres-Gutiérrez, Rodrigo E., et al.
Publicado: (2022)

The hypoxia-inducible factor-1α in stemness and resistance to chemotherapy in gastric cancer: Future directions for therapeutic targeting
por: Ozcan, Gulnihal
Publicado: (2023)

CAMSAP1 Mutation Correlates With Improved Prognosis in Small Cell Lung Cancer Patients Treated With Platinum-Based Chemotherapy
por: Yi, Yonglin, et al.
Publicado: (2022)

Metabolic fingerprinting of chemotherapy-resistant prostate cancer stem cells. An untargeted metabolomic approach by liquid chromatography-mass spectrometry
por: Bort, Alicia, et al.
Publicado: (2022)

Editorial: Personalized medicine for neuromuscular disorders
por: Bartoli, Marc, et al.
Publicado: (2023)

Targeting Strategies for Enhancing Paclitaxel Specificity in Chemotherapy
por: Ma, Yuan, et al.
Publicado: (2021)

The Novel Methylation Biomarker NPY5R Sensitizes Breast Cancer Cells to Chemotherapy
por: Liu, Jiazhou, et al.
Publicado: (2022)

The predictive effect of immune therapy and chemotherapy under T cell-related gene prognostic index for Gastric cancer
por: Chen, Jingyao, et al.
Publicado: (2023)

Mitophagy-Related Gene Signature for Prediction Prognosis, Immune Scenery, Mutation, and Chemotherapy Response in Pancreatic Cancer
por: Zhuo, Zewei, et al.
Publicado: (2022)

Desmoplastic small round cell tumor cancer stem cell-like cells resist chemotherapy but remain dependent on the EWSR1-WT1 oncoprotein
por: Magrath, Justin W., et al.
Publicado: (2022)

Skeletal Muscle Deconditioning in Breast Cancer Patients Undergoing Chemotherapy: Current Knowledge and Insights From Other Cancers
por: Mallard, Joris, et al.
Publicado: (2021)

Identification and Analysis of An Epigenetically Regulated Five-lncRNA Signature Associated With Outcome and Chemotherapy Response in Ovarian Cancer
por: Yang, Hao, et al.
Publicado: (2021)

BCL2A1 and CCL18 Are Predictive Biomarkers of Cisplatin Chemotherapy and Immunotherapy in Colon Cancer Patients
por: Yue, Taohua, et al.
Publicado: (2022)

Prognostic Nutritional Index (PNI) in Patients With Breast Cancer Treated With Neoadjuvant Chemotherapy as a Useful Prognostic Indicator
por: Chen, Li, et al.
Publicado: (2021)

Editorial: Molecular drivers of prostate cancer pathogenesis and therapy resistance
por: Patel, Girijesh Kumar, et al.
Publicado: (2023)

Prediction of Sensitivity and Efficacy of Clinical Chemotherapy Using Larval Zebrafish Patient-Derived Xenografts of Gastric Cancer
por: Zhai, Jing, et al.
Publicado: (2021)

Identification of CHMP7 as a promising immunobiomarker for immunotherapy and chemotherapy and impact on prognosis of colorectal cancer patients
por: Guo, Yu, et al.
Publicado: (2023)

An EMT-Related Gene Signature for Predicting Response to Adjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma
por: Feng, Zengyu, et al.
Publicado: (2021)

Pyruvate Dehydrogenase Contributes to Drug Resistance of Lung Cancer Cells Through Epithelial Mesenchymal Transition
por: Cevatemre, Buse, et al.
Publicado: (2022)

Chemotherapy- and Immune-Related Gene Panel in Prognosis Prediction and Immune Microenvironment of SCLC
por: Chen, Meng-Yu, et al.
Publicado: (2022)

The STRIPAK Complex Regulates Response to Chemotherapy Through p21 and p27
por: Rodriguez-Cupello, Carmen, et al.
Publicado: (2020)

HIF1α Regulates IL17 Signaling Pathway Influencing Sensitivity of Taxane-Based Chemotherapy for Breast Cancer
por: Dai, Huijuan, et al.
Publicado: (2021)

p38MAPK and Chemotherapy: We Always Need to Hear Both Sides of the Story
por: García-Cano, Jesús, et al.
Publicado: (2016)

Editorial: Branching Morphogenesis During Embryonic Lung Development
por: El Agha, Elie, et al.
Publicado: (2021)

Editorial: Tumor Microenvironment and Cancer Cell Interactions in Solid Tumor Growth and Therapy Resistance
por: Ruocco, Maria Rosaria, et al.
Publicado: (2022)

Laminin 332 expression levels predict clinical outcomes and chemotherapy response in patients with pancreatic adenocarcinoma
por: Sari, Bilge, et al.
Publicado: (2023)

Editorial: Non-Coding RNAs in Gastrointestinal and Gynecological Cancers: New Insights Into the Mechanisms of Cancer Therapeutic Resistance
por: Dong, Peixin, et al.
Publicado: (2022)

Immunity-Related Gene Signature Identifies Subtypes Benefitting From Adjuvant Chemotherapy or Potentially Responding to PD1/PD-L1 Blockage in Pancreatic Cancer
por: Qian, Hao, et al.
Publicado: (2021)

Editorial: Multidisciplinary Approaches in Exploring Cancer Heterogeneity, TME and Therapy Resistance: Perspectives for Systems Medicine
por: Pützer, Brigitte M., et al.
Publicado: (2022)

Mitophagy-mediated molecular subtypes depict the hallmarks of the tumour metabolism and guide precision chemotherapy in pancreatic adenocarcinoma
por: Chen, Hao, et al.
Publicado: (2022)

Identification of a Novel Immune Landscape Signature for Predicting Prognosis and Response of Endometrial Carcinoma to Immunotherapy and Chemotherapy
por: Liu, Jinhui, et al.
Publicado: (2021)

Editorial: The development of lethal prostate cancer
por: Zhang, Baotong, et al.
Publicado: (2023)

Overcoming Cancer Drug Resistance Utilizing PROTAC Technology
por: Burke, Matthew R., et al.
Publicado: (2022)

Mechanisms of Pharmaceutical Therapy and Drug Resistance in Esophageal Cancer
por: Mao, Chengyi, et al.
Publicado: (2021)

Editorial: Non-coding RNAs in gastrointestinal and gynecological cancers: New insights into the mechanisms of cancer therapeutic resistance, volume II
por: Dong, Peixin, et al.
Publicado: (2023)

Mechanisms of Senescence-Related NKG2D Ligands Release and Immune Escape Induced by Chemotherapy in Neuroblastoma Cells
por: Zhang, Yan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pr0aidtsld3rvc4afda0l472ej